Cite

HARVARD Citation

    Sartini, A. et al. (n.d.). "Blindly" ADA Dose Escalation to 80 mg Weekly in Crohn's Disease Patients with LOR. Inflammatory bowel diseases. 21 (11), p. . [Online]. 
  
Back to record